• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新诊断肺结核患者合并症的患病率及临床特征:中国东部一项多中心观察性研究

Prevalence and clinical profile of comorbidity among newly diagnosed pulmonary tuberculosis patients: a multi-center observational study in eastern China.

作者信息

Wang Wei, Wang Xiaomeng, Chen Songhua, Li Jun, Cheng Qinglin, Zhang Yu, Wu Qian, Liu Kui, Jiang Xuli, Chen Bin

机构信息

Department of Tuberculosis Control and Prevention, Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou, Zhejiang, China.

Zhejiang Key Lab of Vaccine, Infectious Disease Prevention and Control, Hangzhou, Zhejiang, China.

出版信息

Front Med (Lausanne). 2025 Jan 28;12:1446835. doi: 10.3389/fmed.2025.1446835. eCollection 2025.

DOI:10.3389/fmed.2025.1446835
PMID:39935798
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11810726/
Abstract

OBJECTIVE

To identify the composition of comorbidities among patients with newly diagnosed pulmonary tuberculosis and assess the impact of comorbidities on the clinical characteristics of patients.

METHODS

This study was conducted in 13 hospitals across 13 counties in Zhejiang province, China. Patient data collected in this study included demographic characteristics, chest radiography results, etiological results, and comorbidities. Descriptive statistics were conducted to describe the composition of comorbidities of all participants. Univariate and multivariate logistic regression analyzes were performed to identify the effects of comorbidities on the clinical features of the participants.

RESULTS

Of the 8,421 total participants, 27.6% reported cavities in the chest radiography results, 41.9% were -positive in the etiology test results, and 38.7% (3,258/8,421) had at least one type of comorbidity. The most predominant comorbidity was pleuritis (1,833, 21.8%), followed by diabetes mellitus (763, 9.1%), other extrapulmonary tuberculosis (421, 5%), tracheobronchial tuberculosis (275, 3.3%), and silicosis (160, 1.9%). Participants with diabetes mellitus had the highest rate of chest cavities on X-ray (54.8%), followed by those with silicosis (33.1%). In addition, a higher percentage of the -positive etiology (45%) was observed in participants without comorbidities than in participants with comorbidities (37.1%). Compared to patients without comorbidities, patients with diabetes mellitus (adjusted odds ratio [AOR]: 2.88, 95% confidence interval [CI]: 2.42-3.43) were more likely to show cavities in chest X-ray, while patients with pleuritis (AOR: 0.27, 95% CI: 0.23-0.32), other extrapulmonary tuberculosis (AOR: 0.48, 95% CI: 0.36-0.64), and tracheobronchial tuberculosis (AOR: 0.40-0.79) were less likely to show chest cavities in X-ray. In addition, patients with diabetes mellitus (AOR: 2.05, 95% CI: 1.72-2.45), tracheobronchial tuberculosis (AOR: 3.22, 95% CI: 2.4-4.32) were more likely to show -positive in the etiology, and patients with pleuritis (AOR: 0.25, 95% CI: 0.22-0.29), other extrapulmonary tuberculosis (AOR: 0.61, 95% CI: 0.48-0.76) were less likely to show -positive in the etiology.

CONCLUSION

The prevalence of comorbidities was high in patients newly diagnosed with pulmonary tuberculosis. Thus, integration of screening and personalized management is needed for the control of tuberculosis and its comorbidities.

摘要

目的

确定新诊断肺结核患者的合并症构成,并评估合并症对患者临床特征的影响。

方法

本研究在中国浙江省13个县的13家医院开展。本研究收集的患者数据包括人口统计学特征、胸部X线检查结果、病因学检查结果及合并症。进行描述性统计以描述所有参与者的合并症构成。进行单因素和多因素逻辑回归分析以确定合并症对参与者临床特征的影响。

结果

在8421名参与者中,27.6%的胸部X线检查结果显示有空洞,41.9%的病因学检查结果为阳性,38.7%(3258/8421)至少有一种合并症。最主要的合并症是胸膜炎(1833例,21.8%),其次是糖尿病(763例,9.1%)、其他肺外结核(421例,5%)、气管支气管结核(275例,3.3%)和矽肺(160例,1.9%)。糖尿病患者胸部X线有空洞的比例最高(54.8%),其次是矽肺患者(33.1%)。此外,无合并症参与者的病因学阳性比例(45%)高于有合并症参与者(37.1%)。与无合并症患者相比,糖尿病患者(调整优势比[AOR]:2.88,95%置信区间[CI]:2.42 - 3.43)胸部X线更易出现空洞,而胸膜炎患者(AOR:0.27,95%CI:0.23 - 0.32)、其他肺外结核患者(AOR:0.48,95%CI:0.36 - 0.64)和气管支气管结核患者(AOR:0.40 - 0.79)胸部X线出现空洞的可能性较小。此外,糖尿病患者(AOR:2.05,95%CI:1.72 - 2.45)、气管支气管结核患者(AOR:3.22,95%CI:2.4 - 4.32)病因学更易呈阳性,而胸膜炎患者(AOR:0.25,95%CI:0.22 - 0.29)、其他肺外结核患者(AOR:0.61,95%CI:0.48 - 0.76)病因学呈阳性的可能性较小。

结论

新诊断肺结核患者中合并症的患病率较高。因此,控制结核病及其合并症需要整合筛查和个性化管理。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6933/11810726/917c49a45387/fmed-12-1446835-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6933/11810726/917c49a45387/fmed-12-1446835-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6933/11810726/917c49a45387/fmed-12-1446835-g001.jpg

相似文献

1
Prevalence and clinical profile of comorbidity among newly diagnosed pulmonary tuberculosis patients: a multi-center observational study in eastern China.新诊断肺结核患者合并症的患病率及临床特征:中国东部一项多中心观察性研究
Front Med (Lausanne). 2025 Jan 28;12:1446835. doi: 10.3389/fmed.2025.1446835. eCollection 2025.
2
The effect of diabetes mellitus on tuberculosis in eastern China: A decision-tree analysis based on a real-world study.中国东部地区糖尿病对结核病的影响:基于真实世界研究的决策树分析。
J Diabetes. 2023 Nov;15(11):920-930. doi: 10.1111/1753-0407.13444. Epub 2023 Jul 11.
3
Risk factors for drug-resistant tuberculosis, the association between comorbidity status and drug-resistant patterns: a retrospective study of previously treated pulmonary tuberculosis in Shandong, China, during 2004-2019.耐药结核病的危险因素、合并症状况与耐药模式之间的关系:中国山东 2004-2019 年既往治疗肺结核的回顾性研究。
BMJ Open. 2021 Jun 16;11(6):e044349. doi: 10.1136/bmjopen-2020-044349.
4
Prevalence and Risk Factors of Diabetes in Patients with Active Pulmonary Tuberculosis: A Cross-Sectional Study in Two Financially Affluent China Cities.活动性肺结核患者糖尿病的患病率及危险因素:中国两个经济发达城市的横断面研究
Diabetes Metab Syndr Obes. 2024 Mar 2;17:1105-1114. doi: 10.2147/DMSO.S450507. eCollection 2024.
5
Prior tuberculosis, radiographic lung abnormalities and prevalent diabetes in rural South Africa.南非农村地区既往结核病史、肺部放射影像学异常和常见糖尿病。
BMC Infect Dis. 2024 Jul 11;24(1):690. doi: 10.1186/s12879-024-09583-8.
6
Factors associated with treatment delay among newly diagnosed tuberculosis patients in Dessie city and surroundings, Northern Central Ethiopia: a cross-sectional study.埃塞俄比亚中北部德西市及其周边地区初诊结核病患者治疗延迟的相关因素:一项横断面研究。
BMC Public Health. 2018 Jul 28;18(1):931. doi: 10.1186/s12889-018-5823-9.
7
Delayed diagnosis of tuberculosis in patients with diabetes mellitus co-morbidity and its associated factors in Zhejiang Province, China.中国浙江省合并糖尿病的结核病患者延迟诊断及其相关因素。
BMC Infect Dis. 2021 Mar 18;21(1):272. doi: 10.1186/s12879-021-05929-8.
8
Drug resistance of previously treated tuberculosis patients with diabetes mellitus in Shandong, China.中国山东治疗过的糖尿病合并结核病患者的耐药情况。
Respir Med. 2020 Mar;163:105897. doi: 10.1016/j.rmed.2020.105897. Epub 2020 Feb 7.
9
Non-communicable comorbidities in pulmonary tuberculosis and healthcare utilization: a cross-sectional study of 2021 Indonesian national health insurance data.肺结核中的非传染性合并症与医疗保健利用:对2021年印度尼西亚国家医疗保险数据的横断面研究
Arch Public Health. 2024 Aug 19;82(1):127. doi: 10.1186/s13690-024-01352-y.
10
Association of diabetes and tuberculosis: impact on treatment and post-treatment outcomes.糖尿病与结核病的关联:对治疗和治疗后结果的影响。
Thorax. 2013 Mar;68(3):214-20. doi: 10.1136/thoraxjnl-2012-201756. Epub 2012 Dec 18.

本文引用的文献

1
Landscaping tuberculosis multimorbidity: findings from a cross-sectional study in India.景观结核病共病:来自印度一项横断面研究的结果。
BMC Public Health. 2024 Feb 13;24(1):453. doi: 10.1186/s12889-024-17828-z.
2
The tuberculous pleural effusion.结核性胸腔积液
Breathe (Sheff). 2023 Dec;19(4):230143. doi: 10.1183/20734735.0143-2023. Epub 2023 Dec 19.
3
Managing Comorbidities, Determinants and Disability at Start and End of TB Treatment under Routine Program Conditions in China.在中国常规项目条件下,结核病治疗开始和结束时合并症、决定因素及残疾的管理
Trop Med Infect Dis. 2023 Jun 26;8(7):341. doi: 10.3390/tropicalmed8070341.
4
The effect of diabetes mellitus on tuberculosis in eastern China: A decision-tree analysis based on a real-world study.中国东部地区糖尿病对结核病的影响:基于真实世界研究的决策树分析。
J Diabetes. 2023 Nov;15(11):920-930. doi: 10.1111/1753-0407.13444. Epub 2023 Jul 11.
5
Silicosis and tuberculosis: A systematic review and meta-analysis.矽肺和肺结核:系统评价和荟萃分析。
Pulmonology. 2025 Dec 31;31(1):2416791. doi: 10.1016/j.pulmoe.2023.05.001. Epub 2024 Oct 24.
6
Addressing TB multimorbidity in policy and practice: An exploratory survey of TB providers in 27 high-TB burden countries.在政策与实践中应对结核病合并症:对27个结核病高负担国家的结核病防治人员进行的探索性调查
PLOS Glob Public Health. 2022 Dec 7;2(12):e0001205. doi: 10.1371/journal.pgph.0001205. eCollection 2022.
7
Gender differences in tuberculosis patients with comorbidity: A cross-sectional study using national surveillance data and national health insurance claims data in South Korea.韩国全国监测数据和国民健康保险索赔数据的横断面研究:合并症结核病患者的性别差异。
PLoS One. 2023 Jan 20;18(1):e0280678. doi: 10.1371/journal.pone.0280678. eCollection 2023.
8
Infection among 1,659 Silicosis Patients in Zhejiang Province, China.中国浙江省 1659 例矽肺患者的感染情况。
Microbiol Spectr. 2022 Dec 21;10(6):e0145122. doi: 10.1128/spectrum.01451-22. Epub 2022 Dec 1.
9
Prevalence and risks of tuberculosis multimorbidity in low-income and middle-income countries: a meta-review.中低收入国家结核病合并症的流行情况和风险:一项荟萃分析。
BMJ Open. 2022 Sep 29;12(9):e060906. doi: 10.1136/bmjopen-2022-060906.
10
The Footprint of Diabetes Mellitus on the Characteristics and Response to Anti-Tuberculous Therapy in Patients with Pulmonary Tuberculosis from Saudi Arabia.糖尿病对沙特阿拉伯肺结核患者抗结核治疗特征及反应的影响
Infect Drug Resist. 2021 Dec 10;14:5303-5312. doi: 10.2147/IDR.S344703. eCollection 2021.